{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:41:38Z","timestamp":1787236898233,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbi.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:31:59Z","timestamp":1720441919000},"page":"122-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of \u03b1-synuclein oligomers and phosphorylated \u03b1-synuclein aggregates"],"prefix":"10.1016","volume":"121","author":[{"given":"Hiroo","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Matsuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Saiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuu-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji F.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbi.2024.07.004_b0005","doi-asserted-by":"crossref","first-page":"e14678","DOI":"10.1111\/cns.14678","article-title":"The potential of phosphorylated \u03b1-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy","volume":"30","author":"Abdul-Rahman","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.bbi.2024.07.004_b0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","article-title":"Biology of oligodendrocyte and myelin in the mammalian central nervous system","volume":"81","author":"Baumann","year":"2001","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.bbi.2024.07.004_b0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: A new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.bbi.2024.07.004_b0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00702-021-02383-3","article-title":"Neuropathology of multiple system atrophy: Kurt Jellinger\u2019s legacy","volume":"128","author":"Campese","year":"2021","journal-title":"J. Neural Transm."},{"issue":"19","key":"10.1016\/j.bbi.2024.07.004_b0025","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1042\/BCJ20180297","article-title":"Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons","volume":"475","author":"Chavarr\u00eda","year":"2018","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.bbi.2024.07.004_b0030","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.bbi.2024.07.004_b0035","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"issue":"376","key":"10.1016\/j.bbi.2024.07.004_b0040","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","article-title":"Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders","volume":"8","author":"Daniele","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbi.2024.07.004_b0045","doi-asserted-by":"crossref","unstructured":"Danzer, K. M., Ruf, W. P., Putcha, P., Joyner, D., Hashimoto, BI-TGlabe, C., Hyman, B. T., McLean, P. J., 2011. Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25 (1), 326\u2013336. https:\/\/doi.org\/10.1096\/fj.10-164624.","DOI":"10.1096\/fj.10-164624"},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","article-title":"Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology","volume":"111","author":"Danzer","year":"2009","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0055","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo","volume":"12","author":"Dutta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2024.07.004_b0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2024.07.004_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson\u2019s disease-related A53T \u03b1-synuclein causes neurodegeneration in mice","volume":"3","author":"Gu","year":"2010","journal-title":"Mol. Brain."},{"issue":"Pt 1","key":"10.1016\/j.bbi.2024.07.004_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2818.1986.tb02764.x","article-title":"Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R","volume":"143","author":"Gundersen","year":"1986","journal-title":"Thompson. J Microsc."},{"key":"10.1016\/j.bbi.2024.07.004_b0085","first-page":"1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"39","author":"Guyenet","year":"2010","journal-title":"J. vis. Exp."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/bpa.12678","article-title":"Oligodendroglial \u03b1-synucleinopathy-driven neuroinflammation in multiple system atrophy","volume":"29","author":"Hoffmann","year":"2019","journal-title":"Brain Pathology."},{"issue":"5","key":"10.1016\/j.bbi.2024.07.004_b0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/dvg.20808","article-title":"Gene induction in mature oligodendrocytes with a PLP-tTA mouse line","volume":"50","author":"Inamura","year":"2012","journal-title":"Genesis."},{"key":"10.1016\/j.bbi.2024.07.004_b0100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other Lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnen\/63.1.43","article-title":"Microglial activation parallels system degeneration in multiple system atrophy","volume":"63","author":"Ishizawa","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1789.2007.00855.x","article-title":"Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system)","volume":"28","author":"Ishizawa","year":"2008","journal-title":"Neuropathology."},{"issue":"14","key":"10.1016\/j.bbi.2024.07.004_b0115","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.26052","article-title":"Neuropathology of multiple system atrophy: New thoughts about pathogenesis","volume":"29","author":"Jellinger","year":"2014","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3233\/JAD-170397","article-title":"Multiple system atrophy: An oligodendroglioneural synucleinopathy","volume":"62","author":"Jellinger","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"5","key":"10.1016\/j.bbi.2024.07.004_b0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"\u03b1-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson\u2019s disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2024.07.004_b0130","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2024.07.004_b0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","article-title":"Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and \u03b1-synucleinopathies","volume":"81","author":"Kouli","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41531-021-00264-w","article-title":"Similar neuronal imprint and no cross-seeded fibrils in \u03b1-synuclein aggregates from MSA and Parkinson\u2019s disease","volume":"8","author":"Laferri\u00e8re","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.bbi.2024.07.004_b0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J. Neural Transm."},{"issue":"12","key":"10.1016\/j.bbi.2024.07.004_b0150","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.expneurol.2009.10.005","article-title":"Forebrain overexpression of \u03b1-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption","volume":"221","author":"Lim","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2024.07.004_b0160","doi-asserted-by":"crossref","unstructured":"Lindersson, E., Beedholm, R., H\u00f8jrup, P., Moos, BI-TGai, W., Hendil, K. B., Jensen, P. H., 2004. Proteasomal inhibition by alpha-synuclein filaments and oligomers.J. Biol. Chem.279 (13), 12924\u201312934. https:\/\/doi.org\/10.1074\/jbc.M306390200.","DOI":"10.1074\/jbc.M306390200"},{"key":"10.1016\/j.bbi.2024.07.004_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","article-title":"Extensive uptake of \u03b1-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage","volume":"82","author":"Lindstr\u00f6m","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2024.07.004_b0170","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","article-title":"\u03b1-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading","volume":"134","author":"Loria","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2024.07.004_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582998","article-title":"Arginase 1 insufficiency precipitates amyloid-\u03b2 deposition and hastens behavioral impairment in a mouse model of amyloidosis","volume":"11","author":"Ma","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","article-title":"Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease","volume":"116","author":"Markopoulou","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.bbi.2024.07.004_b0185","doi-asserted-by":"crossref","first-page":"e19772","DOI":"10.1371\/journal.pone.0019772","article-title":"The proteolipid protein promoter drives expression outside of the oligodendrocyte lineage during embryonic and early postnatal development","volume":"6","author":"Michalski","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.bbi.2024.07.004_b0190","doi-asserted-by":"crossref","unstructured":"Miller, S. D., Karpus, W. J., 2007. Experimental autoimmune encephalomyelitis in the mouse. Curr. Protoc. Immunol., Chapter 15, 15.1.1\u201315.1.18. https:\/\/doi.org\/10.1002\/0471142735.im1501s77.","DOI":"10.1002\/0471142735.im1501s77"},{"issue":"2","key":"10.1016\/j.bbi.2024.07.004_b0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/neup.12243","article-title":"Accumulation of phosphorylated \u03b1-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration","volume":"36","author":"Nakamura","year":"2016","journal-title":"Neuropathology."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0200","doi-asserted-by":"crossref","first-page":"e13131","DOI":"10.1111\/bpa.13131","article-title":"Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal\/paranodal pathology are characteristic of multiple system atrophy","volume":"33","author":"Nishimura","year":"2022","journal-title":"Brain Pathol."},{"issue":"21","key":"10.1016\/j.bbi.2024.07.004_b0205","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: A field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron."},{"issue":"1\u20133","key":"10.1016\/j.bbi.2024.07.004_b0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.bbi.2024.07.004_b0215","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging."},{"issue":"4","key":"10.1016\/j.bbi.2024.07.004_b0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.bbi.2024.07.004_b0225","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.bbagen.2014.02.013","article-title":"Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells","volume":"1840","author":"Plotegher","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"issue":"5321","key":"10.1016\/j.bbi.2024.07.004_b0230","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","article-title":"Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: Translational implications for interventional therapies","volume":"6","author":"Refolo","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbi.2024.07.004_b0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fncel.2019.00263","article-title":"Neuroinflammation and glial phenotypic changes in alpha-synucleinopathies","volume":"13","author":"Refolo","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"Pt 6","key":"10.1016\/j.bbi.2024.07.004_b0245","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/brain\/awv040","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain","volume":"138","author":"Roberts","year":"2015","journal-title":"Brain."},{"issue":"12","key":"10.1016\/j.bbi.2024.07.004_b0250","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jnen\/nlw087","article-title":"Shared and distinct patterns of oligodendroglial response in \u03b1-synucleinopathies and tauopathies","volume":"75","author":"Rohan","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"49","key":"10.1016\/j.bbi.2024.07.004_b0255","doi-asserted-by":"crossref","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","article-title":"Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes","volume":"37","author":"Rostami","year":"2017","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2024.07.004_b0260","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","article-title":"Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation","volume":"137","author":"Sekiya","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40478-022-01440-6","article-title":"Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease","volume":"10","author":"Sekiya","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"46","key":"10.1016\/j.bbi.2024.07.004_b0270","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","article-title":"Neurological and neurodegenerative alterations in a transgenic mouse model expressing human \u03b1-synuclein under oligodendrocyte promoter: Implications for multiple system atrophy","volume":"25","author":"Shults","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2024.07.004_b0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41583-023-00697-7","article-title":"Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms","volume":"24","author":"Stefanova","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2024.07.004_b0280","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.expneurol.2010.05.008","article-title":"Targeted overexpression of human \u03b1-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure","volume":"224","author":"Stemberger","year":"2010","journal-title":"Exp. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.bbi.2024.07.004_b0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1984.tb02501.x","article-title":"The unbiased estimation of number and sizes of arbitrary particles using the disector","volume":"134","author":"Sterio","year":"1984","journal-title":"J. Microsc."},{"key":"10.1016\/j.bbi.2024.07.004_b0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.nbd.2019.03.020","article-title":"A mouse model of adult-onset multiple system atrophy","volume":"127","author":"Tanji","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"Pt 1","key":"10.1016\/j.bbi.2024.07.004_b0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awp282","article-title":"Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation","volume":"133","author":"Tong","year":"2010","journal-title":"Brain."},{"issue":"11","key":"10.1016\/j.bbi.2024.07.004_b0300","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"issue":"1","key":"10.1016\/j.bbi.2024.07.004_b0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-017-0863-0","article-title":"Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine\/chemokine profiles: A case control study","volume":"14","author":"Yamasaki","year":"2017","journal-title":"J. Neuroinflammation."},{"issue":"6","key":"10.1016\/j.bbi.2024.07.004_b0310","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","article-title":"Mouse model of multiple system atrophy \u03b1-synuclein expression in oligodendrocytes causes glial and neuronal degeneration","volume":"45","author":"Yazawa","year":"2005","journal-title":"Neuron."},{"issue":"2","key":"10.1016\/j.bbi.2024.07.004_b0315","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1084-9521(02)00018-6","article-title":"Tetracycline-controlled transcriptional regulation systems: Advances and application in transgenic animal modeling","volume":"13","author":"Zhu","year":"2002","journal-title":"Semin. Cell Dev. Biol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124004744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124004744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:31:33Z","timestamp":1728307893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124004744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":63,"alternative-id":["S0889159124004744"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.07.004","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of \u03b1-synuclein oligomers and phosphorylated \u03b1-synuclein aggregates","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}